Kelemen Vicki 4
4 · Cardiff Oncology, Inc. · Filed Jun 14, 2021
Insider Transaction Report
Form 4
Kelemen Vicki
Exec. VP and COO
Transactions
- Award
Stock Options
2021-06-10+200,928→ 402,768 totalExercise: $7.98Exp: 2031-06-10→ Common Stock (200,928 underlying)
Footnotes (1)
- [F1]50,232 vest on 6/10/2022. 4,186 vest monthly for 36 months beginning on 7/10/2022 through 6/10/2025.